Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
20 /100
LOW RISK
Score updated Aug 28, 2026

BNTX — BioNTech SE Dilution Risk Tracker

Track BNTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BNTX — Get alerts when the score changes →

As of August 28, 2026, BioNTech SE (BNTX) has a DilutionWatch DilutionScore of 20/100, rated LOW dilution risk. BioNTech SE has a market capitalization of $24.26B, 239.97M shares outstanding, 274 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BNTX.
🔔 Track BNTX — Get forecast alerts →

Market Data

Market Cap$24.26B
Shares Outstanding239.97M
Float110.10M
Cash$15.98B
Debt$353.04M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 0.3% shares (2026Q1 vs prior)
274 institutional holders · 54.43M shares
#1 T. Rowe Price Investment Management, Inc. 5.86M shares
#2 FMR LLC 5.71M shares
#3 PRIMECAP MANAGEMENT CO/CA/ 3.79M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.47M
Days to Cover3.3
% of Float2.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

3 FORM3 2026-03-25
3 FORM3 2026-03-25
3 FORM3 2026-03-25
3 FORM3 2026-03-25
3 FORM3 2026-03-25
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BNTX Dilution Snapshot

BioNTech SE (BNTX) has a DilutionScore of 20/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BNTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BNTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BNTX
BNTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.